Apolipoprotein A5 gene polymorphism and risk for metabolic syndrome: A meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 10, 2012, Pages 1241-1245

  Liu, Cun Fei ^a   Yang, Qun Fang ^a   Chen, Xing Lin ^a   Liu, Cheng Yun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5;

ALLELE; ARTICLE; DATA BASE; DATA EXTRACTION; DNA POLYMORPHISM; ETHNICITY; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INFORMATION PROCESSING; META ANALYSIS; METABOLIC SYNDROME X;

ADULT; AGED; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84867562427     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0183     Document Type: Article

References (32)

1. Alberti KG, Eckel RH, Grundy SM, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
2. Baum L, Tomlinson B, Thomas GN (2003) APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 63:377-379.
3. Beckstead JA, Oda MN, Martin DD, et al. (2003) Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 42:9416-9423.
4. Chen W, Srinivasan SR, Elkasabany A, et al. (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145:197-205.
5. Dallongeville J, Cottel D, Wagner A, et al. (2008) The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet 9:84.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497.
7. Grallert H, Sedlmeier EM, Huth C, et al. (2007) APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 48:2614-2621.
8. Grundy SM. (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399-404.
9. Hamid YH, Rose CS, Urhammer SA, et al. (2005) Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48:251-260.
10. Hong Y, Pedersen NL, Brismar K, et al. (1997) Genetic and environmental architecture of the features of the insulinresistance syndrome. Am J Hum Genet 60:143-152.
11. Hsu LA, Ko YL, Chang CJ, et al. (2008) Apolipoprotein A5 gene-1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin Chem Lab Med 46:1714-1719.
12. Hubacek JA (2005) Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med 43:897-902.
13. Kisfali P, Mohas M, Maasz A, et al. (2010) Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 20:505-511.
14. Komurcu-Bayrak E, Onat A, Poda M, et al. (2008) Gender-modulated impact of apolipoprotein A5 gene (APOA5)-1131T>C and c.56C>G polymorphisms on lipids, dyslipi-demia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 46:778-784.
15. Lin HF, Boden-Albala B, Juo SH, et al. (2005) Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 48:2006-2012.
16. Lookene A, Beckstead JA, Nilsson S, et al. (2005) Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem 280:25383-25387.
17. Matsunaga A, Arishima H, Niimura H, et al. (2007) Strong linkage disequilibrium and association of-1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hyper-triglyceridemia in a Japanese population. Circ J 71:746-752.
18. Mattei J, Demissie S, Tucker KL, et al. (2009) Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J Nutr 139:2301-2308.
19. Merkel M, Loeffler B, Kluger M, et al. (2005) Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280:21553-21560.
20. Niculescu LS, Vladica M, Sima AV (2010) Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome. Biochem Bio-phys Res Commun 391:587-591.
21. Nilsson SK, Lookene A, Beckstead JA, et al. (2007) Apolipo-protein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 46:3896-3904.
22. Ong KL, Jiang CQ, Liu B, et al. (2011) Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clin Endocrinol (Oxf) 74:206-213.
23. Pennacchio LA, Olivier M, Hubacek JA, et al. (2001) An apoli-poprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173.
24. Pennacchio LA, Olivier M, Hubacek JA, et al. (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038.
25. Schaap FG, Rensen PC, Voshol PJ, et al. (2004) ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279:27941-27947.
26. van der Vliet HN, Sammels MG, Leegwater AC, et al. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512-44520.
27. van der Vliet HN, Schaap FG, Levels JH, et al. (2002) Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295:1156-1159.
28. van Dijk KW, Rensen PC, Voshol PJ, et al. (2004) The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol 15:239-246.
29. Vasilopoulos Y, Sarafidou T, Bagiatis V, et al. (2011) Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population. Genet Test Mol Biomarkers 15:613-617.
30. Weinberg RB, Cook VR, Beckstead JA, et al. (2003) Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 278:34438-34444.
31. Yamada Y, Kato K, Hibino T, et al. (2007) Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191:298-304.
32. Zhou D, Liu H, Zhou M, et al. (2012) Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol Biol Rep 39:6555-651.